Tag: Daniel R. Henderson

Verndari begins preclinical testing of COVID-19 vaccine candidate

pharmanewsdaily- April 30, 2020

Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered using it microneedle array dermal patch VaxiPatch. ... Read More